Diabetics and Thyroid Cancer Health Alert: The Diabetes Drug Byetta Has Been Linked To An Increased Risk of Thyroid Cancer By Diabetes Thyroid Cancer Lawyer Jason S. Coomer
Each year an increasing number of people are newly diagnosed with thyroid cancer. In 2012 there were more than 200,000 people newly diagnosed with thyroid cancer. A growing number of people with thyroid cancer are diabetics. One reason for the growing number of people with thyroid cancer and the increase of diabetics with thyroid cancer is that some diabetes drugs including Byetta cause an increase risk of thyroid cancer. Diabetics and their health care provides should be aware of this health risk and make health care decisions with cancer risks in mind.
Diabetes Drug Cancer Lawsuits and Byetta Thyroid Cancer Lawsuits
Several Diabetes Drug Cancer Lawsuits are now being filed against drug manufacturers that intentionally hid known dangers of diabetic medications and/or failed to provide adequate warnings to consumers regarding cancer risks of diabetes medications. For more information on these diabetes drug cancer lawsuits, please go to the following webpage: Diabetes Drug Cancer Lawsuits.
Individuals that have been diagnosed with thyroid cancer and have taken Byetta as well as families that have lost a loved one to thyroid cancer and that loved one was taking Byetta may be entitled to financial compensation and are strongly encouraged to have their potential case reviewed. For more information on Byetta Thyroid Cancer Lawsuits and Byetta Pancreatic Cancer Lawsuits, please go to the following webpage Byetta Thyroid Cancer Lawsuits.
FDA Adverse Events Have Shown Byetta May Cause An Increased Risk of Thyroid Cancer and Pancreatic Cancer: Persons Taking Byetta That Have Been Diagnosed With Pancreatic Cancer or Thyroid Cancer as well as Their Doctors and Families Are Encouraged To Report Adverse Events To The FDA
In July 2011, researchers at the University of California, Los Angeles studied the connection between Byetta and pancreatic cancer, pancreatitis, and thyroid cancer by combing FDA adverse events reports. They calculated a sixfold increase in users developing pancreatitis, and Byetta increased the likelihood of pancreatic cancer by 2.9 times. The lead researcher, Dr. Peter Butler, cautioned that the results do not account for increased Byetta side effects reporting by doctors. The study appeared in the journal of Gastroenterology.
In 2009, the U.S. Food and Drug Administration (FDA) published a Drug Safety Communication to announce that drug-makers Amylin Pharmaceuticals and Eli Lilly Co. must conduct 6 post-marketing surveillance studies to better understand the potential link between Byetta and thyroid cancer. The result of these studies are still pending.
Persons who are taking Byetta and who have been diagnosed with pancreatic cancer or thyroid cancer and their families are strongly encouraged to report adverse events to the FDA to ensure that all cancer risks are properly reviewed and placed on any future Byetta warnings.